Used in the treatment of type 2 diabetes as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It helps lower blood glucose levels by promoting the excretion of excess glucose through urine. This compound improves glycemic control without increasing insulin secretion, making it beneficial for patients with insulin resistance. It is often prescribed as part of a broader diabetes management plan that includes diet and exercise. Additional benefits include modest reductions in body weight and blood pressure.

Furthermore, research has found that this class of compounds may provide cardiovascular benefits, helping to reduce the risk of death from heart disease, heart failure, and hospitalization due to heart problems.

Generally, this compound is used in combination with other diabetes medications, along with diet and exercise control.